An article in Newsweek magazine reports on speakers and topics from the recent Horizons conference in New York City. In “Ecstasy and Acid in Your Medicine Cabinet? Doctors Explore Psychedelics,” published on October 14th, 2014, writer Douglas Main provides an overview of past and current psychedelic research. The article mentions several studies on psilocybin by Heffter researchers.

“Psilocybin, the active ingredient in so-called ‘magic mushrooms,’ has been shown to reduce anxiety and depression in several small studies, including one 2010 study at UCLA published in Archives of General Psychiatry and another in progress at Johns Hopkins. A paper that came out this spring done by researchers from the Psychiatric University Hospital of Zurich published in the journal Biological Psychiatry found that psilocybin decreases activity in the amygdala, the part of the brain that may be overactive in people with anxiety and depression.”

Ecstasy and Acid in Your Medicine Cabinet? Doctors Explore Psychedelics | Newsweek